Vertical integration for CDMOs in manufacturing ADCs offers an opportunity to reduce costs and create a more resilient supply ...

BMS looks forward to pivotal readouts for six assets in 2026, ensuring profits after patent expiries for Opdivo and Eliquis.

SciNeuro Pharmaceuticals has announced a global licensing and collaboration agreement with Novartis to develop SciNeuro’s ...

Shifting regulatory policies and evolving US drug pricing dynamics have created a favourable environment for deals.

Atara Biotherapeutics has announced that the US Food and Drug Administration (FDA) has issued a CRL for the BLA of Ebvallo ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Launching a new product in a packed pharmaceutical market requires an incisive marketing strategy. Learn more here: ...

Healthcare is moving its focus from the quantity of real-world data (RWD) to quality, with targeted AI a key tool. We explore ...

AbbVie's deal with RemeGen is the first to be announced during the 2026 J.P Morgan Healthcare Conference, with more deals ...

Eli Lilly is reportedly looking to acquire French biotech Abivax, sending the latter company’s shares surging ahead of the ...

Multiple big pharma companies are reported to be circling Revolution, a cancer biotech with a market cap of $23bn.

Sino Biological on Inside Business Today. This video explores Sino Biological's contribution to biomedical research, as well ...